These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 7094439

  • 1. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.
    Fleming LW, Stewart Wk, Fell GS, Halls DJ.
    Clin Nephrol; 1982 May; 17(5):222-7. PubMed ID: 7094439
    [Abstract] [Full Text] [Related]

  • 2. Plasma aluminium levels in patients on maintenance haemodialysis fall when oral aluminium hydroxide is withdrawn.
    Wallace MR, Pybus J.
    N Z Med J; 1983 Oct 26; 96(742):793-5. PubMed ID: 6578451
    [Abstract] [Full Text] [Related]

  • 3. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
    Tahiri Y, Moriniere P, Jaudon MC, Dkhissi H, Rosa A, Fournier A.
    Nephrologie; 1983 Oct 26; 4(3):129-33. PubMed ID: 6633778
    [Abstract] [Full Text] [Related]

  • 4. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area of low water aluminium.
    Pybus J, Doak PB.
    Clin Nephrol; 1983 Jul 26; 20(1):53-4. PubMed ID: 6883822
    [No Abstract] [Full Text] [Related]

  • 5. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.
    Zumkley H, Bertram HP, Lison A, Knoll O, Losse H.
    Clin Nephrol; 1979 Jul 26; 12(1):18-21. PubMed ID: 477052
    [Abstract] [Full Text] [Related]

  • 6. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency].
    Sárszegi Z, Jobst K, Nagy J.
    Orv Hetil; 2000 Aug 27; 141(35):1915-7. PubMed ID: 11019592
    [Abstract] [Full Text] [Related]

  • 7. Hyperaluminaemia associated with oral citrate and aluminium hydroxide.
    Kirschbaum BB, Schoolwerth AC.
    Hum Toxicol; 1989 Jan 27; 8(1):45-7. PubMed ID: 2714810
    [Abstract] [Full Text] [Related]

  • 8. Value of serum aluminium monitoring in dialysis patients: a multicentre study.
    D'Haese PC, Clement JP, Elseviers MM, Lamberts LV, Van de Vyver FL, Visser WJ, De Broe ME.
    Nephrol Dial Transplant; 1990 Jan 27; 5(1):45-53. PubMed ID: 2109284
    [Abstract] [Full Text] [Related]

  • 9. [Determination of the plasma aluminum concentration of hemodialysis patients].
    Kuleva V, Petrov I, Antonov S, Kiriakov Z.
    Vutr Boles; 1984 Jan 27; 23(2):51-5. PubMed ID: 6741112
    [Abstract] [Full Text] [Related]

  • 10. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
    Boukari M, Rottembourg J, Jaudon MC, Clavel JP, Legrain M, Galli A.
    Nouv Presse Med; 1978 Jan 14; 7(2):85-8. PubMed ID: 349501
    [Abstract] [Full Text] [Related]

  • 11. Aluminium load in patients with analgesic nephropathy.
    Schwarz A, Kraft D, Keller F, Gawlik D, Offermann G.
    Miner Electrolyte Metab; 1987 Jan 14; 13(3):141-6. PubMed ID: 3627045
    [Abstract] [Full Text] [Related]

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 14; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 13. Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.
    Mazzeo-Farina A, Cerulli N.
    Clin Chim Acta; 1985 Apr 30; 147(3):247-54. PubMed ID: 3995774
    [Abstract] [Full Text] [Related]

  • 14. Correction of high serum aluminium in a patient on maintenance haemodialysis.
    Wallace MR.
    N Z Med J; 1981 May 27; 93(684):335-7. PubMed ID: 6942294
    [Abstract] [Full Text] [Related]

  • 15. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM, Allen KR, Newton KE.
    Ann Clin Biochem; 2005 Jan 27; 42(Pt 1):51-4. PubMed ID: 15802033
    [Abstract] [Full Text] [Related]

  • 16. Serum aluminium measurement by DC plasma emission spectrometry.
    Roberts NB, Williams P.
    Ann Clin Biochem; 1988 Mar 27; 25 ( Pt 2)():169-75. PubMed ID: 3382147
    [Abstract] [Full Text] [Related]

  • 17. The dialysis dementia syndrome and aluminum intoxication.
    Sideman S, Manor D.
    Nephron; 1982 Mar 27; 31(1):1-10. PubMed ID: 7110469
    [No Abstract] [Full Text] [Related]

  • 18. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption.
    Heaf JG, Nielsen LP.
    Miner Electrolyte Metab; 1984 Mar 27; 10(6):345-50. PubMed ID: 6503890
    [Abstract] [Full Text] [Related]

  • 19. Rapid alterations in plasma aluminium in association with varied oral aluminium intake in dialysis patients.
    Boyce NW, Holdsworth SR, Thomson NM, Atkins RC.
    Nephron; 1987 Mar 27; 45(2):164. PubMed ID: 3561627
    [No Abstract] [Full Text] [Related]

  • 20. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG, Pødenphant J, Andersen JR.
    Nephron; 1986 Mar 27; 42(3):210-6. PubMed ID: 3945361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.